OtherVC-backedSeries C
San Diego, United States · Founded 2020
Iambic Therapeutics
AI-discovered small-molecule drugs.
About Iambic Therapeutics
Generative-AI drug discovery — multiple oncology candidates in clinical trials. Among the most advanced AI-pharma plays.
Company facts
- Category
- Other
- Funding stage
- Series C
- Total raised
- $220M+
- Founded
- 2020
- Team size
- 51-200
- HQ
- San Diego
- Country
- United States
- Website
- iambic.ai
Founders of Iambic Therapeutics
- Tom Miller
- Fred Manby
Investors backing Iambic Therapeutics
- Nextech
- Catalio Capital Management
Frequently asked questions
What does Iambic Therapeutics do?
Generative-AI drug discovery — multiple oncology candidates in clinical trials. Among the most advanced AI-pharma plays.
Where is Iambic Therapeutics based?
Iambic Therapeutics is based in San Diego, United States.
When was Iambic Therapeutics founded?
Iambic Therapeutics was founded in 2020.
How much has Iambic Therapeutics raised?
Iambic Therapeutics has raised $220M+ in their Series C round.
Who founded Iambic Therapeutics?
Iambic Therapeutics was founded by Tom Miller, Fred Manby.
Who has invested in Iambic Therapeutics?
Iambic Therapeutics is backed by Nextech, Catalio Capital Management.